PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 50 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $116,000 | -71.8% | 665,563 | -2.7% | 0.00% | – |
| Q2 2022 | $411,000 | -54.3% | 684,204 | +0.4% | 0.00% | – |
| Q1 2022 | $899,000 | -49.7% | 681,491 | -0.6% | 0.00% | – |
| Q4 2021 | $1,789,000 | +10.8% | 685,397 | +32.0% | 0.00% | – |
| Q3 2021 | $1,615,000 | -10.9% | 519,359 | +6.6% | 0.00% | – |
| Q2 2021 | $1,812,000 | -57.0% | 487,024 | -60.1% | 0.00% | – |
| Q1 2021 | $4,218,000 | +5.2% | 1,219,125 | +2.1% | 0.00% | – |
| Q4 2020 | $4,010,000 | +0.7% | 1,193,607 | +5.2% | 0.00% | – |
| Q3 2020 | $3,984,000 | -20.0% | 1,134,939 | +4.9% | 0.00% | – |
| Q2 2020 | $4,977,000 | +51.9% | 1,082,169 | +9.3% | 0.00% | – |
| Q1 2020 | $3,276,000 | -46.4% | 989,790 | -1.0% | 0.00% | – |
| Q4 2019 | $6,108,000 | +59.3% | 999,708 | +8.7% | 0.00% | – |
| Q3 2019 | $3,835,000 | -67.4% | 920,042 | +2.7% | 0.00% | -100.0% |
| Q2 2019 | $11,748,000 | +2632.1% | 895,427 | +1878.4% | 0.00% | – |
| Q1 2019 | $430,000 | +444.3% | 45,261 | +78.8% | 0.00% | – |
| Q4 2018 | $79,000 | – | 25,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |